Does AGALSIDASE BETA Cause Central venous catheterisation? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Central venous catheterisation have been filed in association with AGALSIDASE BETA (Fabrazyme). This represents 0.2% of all adverse event reports for AGALSIDASE BETA.
12
Reports of Central venous catheterisation with AGALSIDASE BETA
0.2%
of all AGALSIDASE BETA reports
0
Deaths
4
Hospitalizations
How Dangerous Is Central venous catheterisation From AGALSIDASE BETA?
Of the 12 reports, 4 (33.3%) required hospitalization.
Is Central venous catheterisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AGALSIDASE BETA. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does AGALSIDASE BETA Cause?
Malaise (409)
Pain (395)
Pyrexia (362)
Fatigue (338)
Nausea (303)
Weight decreased (272)
Headache (269)
Dyspnoea (266)
Chills (259)
Vomiting (244)
What Other Drugs Cause Central venous catheterisation?
EPOPROSTENOL (361)
AMBRISENTAN (263)
TREPROSTINIL (208)
ECULIZUMAB (105)
VENETOCLAX (89)
MACITENTAN (78)
PEMBROLIZUMAB (70)
AZTREONAM LYSINE (63)
ADALIMUMAB (59)
NATALIZUMAB (57)
Which AGALSIDASE BETA Alternatives Have Lower Central venous catheterisation Risk?
AGALSIDASE BETA vs AGOMELATINE
AGALSIDASE BETA vs ALAWAY
AGALSIDASE BETA vs ALBENDAZOLE
AGALSIDASE BETA vs ALBIGLUTIDE
AGALSIDASE BETA vs ALBUMIN